ClinConnect ClinConnect Logo
Search / Trial NCT06822257

Drinking in Young Adult Duos (DYAD) Study

Launched by CARNEGIE MELLON UNIVERSITY · Feb 6, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Alcohol Administration Couples

ClinConnect Summary

The Drinking in Young Adult Duos (DYAD) Study is looking at how alcohol use can affect romantic relationships. In this study, couples aged 21 to 30 who regularly drink alcohol will participate in a session where they will either drink an alcoholic beverage or a non-alcoholic one and complete some tasks together. After the session, they will share their drinking habits and experiences related to alcohol and their relationship through quick surveys on their smartphones. They will also check in again at 6 months and 12 months to see how things have changed.

To be eligible for the study, both partners in the couple must be between 21 and 30 years old, drink alcohol regularly, and own a smartphone. However, people who have had serious problems with alcohol, are pregnant, or have certain health issues that could be worsened by drinking are not allowed to participate. This study aims to help us understand how drinking affects relationships, which could lead to better strategies for promoting healthier behaviors in couples.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both members of the couple must:
  • be between the ages of 21 and 30
  • regularly consume alcohol
  • own a smartphone
  • Exclusion Criteria:
  • Neither member of the couple:
  • has a history of adverse reaction to the amount of beverage used in the study
  • has a history of major problems related to alcohol
  • is taking medications that could adversely interact with alcohol
  • is pregnant

About Carnegie Mellon University

Carnegie Mellon University is a prestigious research institution renowned for its innovative contributions to science, technology, and the arts. As a clinical trial sponsor, the university leverages its interdisciplinary expertise and cutting-edge research facilities to advance medical knowledge and improve patient outcomes. With a commitment to ethical research practices and collaboration with industry partners, Carnegie Mellon University aims to facilitate groundbreaking clinical studies that address critical health challenges and foster the development of novel therapeutic interventions.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported